ESMO Preceptorship on NSCLC 2024: Helsinki

22 - 23 May 2024

Helsinki, Finland

ESMO-Preceptorship-Lung-Cancer-1000x1000

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Meeting programme Next/upcoming meetings

Learning objectives

To learn about best clinical practice in the management of Non-Small-Cell Lung Cancer (NSCLC) in the adjuvant, locally advanced and metastatic setting
To understand the importance of pathology, histo-prognostic and molecular factors and liquid biopsies in the management of NSCLC
To learn about the management of patients after progression, side effects of treatments and the use of targeted agents in NSCLC and obtain some highlights of ongoing clinical research

This event has been supported by an unrestricted education grant from MSD and Roche.

Hide

There are 27 resources available